Ambulatory Blood Pressure Monitoring Market By Procedure 2021 | IndustryARC
  • 1-614-588-8538 (Ext: 101)
  • US Toll Free

Ambulatory Blood Pressure Monitoring Market
Ambulatory Blood Pressure Monitoring Market Analysis: By Procedure (Invasive, Non-Invasive); By End-use (Hospital, Home Care Settings, Surgical Centers & Clinics, Diagnostic Laboratories and Others); By Product and Geography – Forecast to 2021
Report Code : HCR 0113
Published: 18 March, 2016   No. of pages: 144

  • Report Description
  • Table of Contents
  • Customization Options
Ambulatory blood pressure monitoring is defined as the frequent measurement of blood pressure after fixed interval of time which usually varies from 15 to 30 minutes and the monitoring of patient is performed for 24 hours of time. The procedure is majorly used to monitor patients suffering from hypertension due to increased monitoring, masked hypertension, episodic hypertension, hypertension due to anti-hypersensitive medicine and to differentiate white-collar and true hypertension.

This report identifies the Ambulatory Blood Pressure Monitoring market size in terms of value for the year 2014-2016, and forecast of the same for year 2021. It highlights potential growth opportunities in the coming years, while also reviewing the market drivers, restraints, growth indicators, challenges, market dynamics, competitive landscape, and other key aspects with respect to Ambulatory Blood Pressure Monitoring market.
  • This report has been divided based on product type which includes Ambulatory BP Monitors, Sphygmomanometers, BP Transducers, BP Cuffs and Others.
  • This report also includes Ambulatory Blood Pressure Monitoring market by Procedure type which includes Invasive and Non-Invasive procedure.
  • The report is also segmented on the basis of the end-use into Hospital, Home Care Settings, Ambulatory Surgical Centers & Clinics, Diagnostic Laboratories and Others.
  • This report has been further segmented into major regions, which includes detailed analysis of each region such as Americas, Europe, Asia-Pacific (APAC) and Rest of the World (RoW). 

Country level markets for each of the regions are also analyzed and determined. The major countries considered under the Americas region are Argentina, Brazil and the North American region. The major countries considered under the Asia-Pacific region are China, Japan, India, South Korea and others. The major countries considered under the European region are United Kingdom, France, Germany and others.

Ambulatory blood pressure monitoring

Globally demand for Ambulatory Blood Pressure Monitoring is expected to witness growth in the upcoming future due to rapidly increasing prevalence of Chronic & Acute Diseases and the rapid increase in aging population. The major factor restraining the substantial growth of Ambulatory Blood Pressure Monitoring is the high cost of technological development and availability of low-cost devices. North America and Europe has the highest markets share by value in global Ambulatory Blood Pressure Monitoring market and Asia Pacific region is projected to have a significant growth during the forecast period.

This market research report includes in depth analysis of Ambulatory Blood Pressure Monitoring in each application and in the regional segment separately to provide in depth view of key insights and market scenario. Forecasts are also provided for all the market segments for the period 2016-2021.

This report also includes detailed profiling of following the major players in the global Ambulatory Blood Pressure Monitoring market:
  • Philips Healthcare
  • GE Healthcare
  • Medtronic PLC
  • Drägerwerk Ag & Co. KGAA
  • Welch Allyn
1. Ambulatory Blood Pressure Monitoring  – Market Overview
2. Executive Summary
3. Ambulatory Blood Pressure Monitoring  – Market Landscape

   3.1. Market Share Analysis
   3.2. Comparative Analysis
      3.2.1. Product Benchmarking
      3.2.2. End User Profiling
      3.2.3. Top 5 Financials Analysis
4. Ambulatory Blood Pressure Monitoring – Market Forces
   4.1. Market Drivers
      4.1.1. Rapidly increasing prevalence of Chronic and Acute Diseases
      4.1.2. Rapid increase in Aging Population
   4.2. Market Constraints
      4.2.1. High Cost of Technological Development
      4.2.2. Availability of Low-Cost Devices
   4.3. Market Challenges
      4.3.1. Regulatory Hurdles
   4.4. Attractiveness of the Ambulatory Blood Pressure Monitoring Industry
      4.4.1. Power of Suppliers
      4.4.2. Power of Customers
      4.4.3. Threat of New Entrants
      4.4.4. Threat of Substitution
      4.4.5. Degree of Competition
5. Ambulatory Blood Pressure Monitoring Market – Strategic Analysis
   5.1. Value Chain Analysis
   5.2. Pricing Analysis
   5.3. Opportunities Analysis
   5.4. Product/Market Life Cycle Analysis
   5.5. Suppliers and Distributors
6. Ambulatory Blood Pressure Monitoring Market – By Procedure
   6.1. Invasive
   6.2. Non-Invasive
7. Ambulatory Blood Pressure Monitoring Market- By End-Use
   7.1. Hospital
   7.2. Home Care Settings
   7.3. Ambulatory Surgical Centers and Clinics
   7.4. Diagnostic Laboratories and
   7.5. Others
8. Ambulatory Blood Pressure Monitoring Market- By Product
   8.1. Ambulatory BP Monitors
   8.2. Sphygmomanometers
   8.3. BP Transducers
   8.4. BP Cuffs
   8.5. Others
9. Ambulatory Blood Pressure Monitoring Market - By Geography
   9.1. Introduction
   9.2. Global Study
   9.3. Americas
      9.3.1. North America
      9.3.2. Brazil
      9.3.3. Argentina
      9.3.4. Others
   9.4. Europe
      9.4.1. U.K.
      9.4.2. France
      9.4.3. Germany
      9.4.4. Others
   9.5. APAC
      9.5.1. China
      9.5.2. South Korea
      9.5.3. Japan
      9.5.4. India
      9.5.5. Others
   9.6. ROW
10. Ambulatory Blood Pressure Monitoring Market Entropy
   10.1. New Product Launches
   10.2. M&As, Collaborations, JVs and Partnerships
11. Company Profiles
   11.1. Philips Healthcare
      11.1.1. Introduction
      11.1.2. Financials
      11.1.3. Key Insights
      11.1.4. Key Strategy
      11.1.5. Product Portfolio
      11.1.6. SWOT Analysis
   11.2. GE Healthcare
      11.2.1. Introduction
      11.2.2. Financials
      11.2.3. Key Insights
      11.2.4. Key Strategy
      11.2.5. Product Portfolio
      11.2.6. SWOT Analysis
   11.3. Medtronic PLC
      11.3.1. Introduction
      11.3.2. Financials
      11.3.3. Key Insights
      11.3.4. Key Strategy
      11.3.5. Product Portfolio
      11.3.6. SWOT Analysis
   11.4. Drägerwerk Ag & Co. KGAA
      11.4.1. Introduction
      11.4.2. Financials
      11.4.3. Key Insights
      11.4.4. Key Strategy
      11.4.5. Product Portfolio
      11.4.6. SWOT Analysis
   11.5. Welch Allyn
      11.5.1. Introduction
      11.5.2. Financials
      11.5.3. Key Insights
      11.5.4. Key Strategy
      11.5.5. Product Portfolio
      11.5.6. SWOT Analysis
   11.6. Becton, Dickinson and Company
      11.6.1. Introduction
      11.6.2. Financials
      11.6.3. Key Insights
      11.6.4. Key Strategy
      11.6.5. Product Portfolio
      11.6.6. SWOT Analysis
   11.7. Nihon Kohden Corporation
      11.7.1. Introduction
      11.7.2. Financials
      11.7.3. Key Insights
      11.7.4. Key Strategy
      11.7.5. Product Portfolio
      11.7.6. SWOT Analysis
   11.8. Nonin Medical Inc.
      11.8.1. Introduction
      11.8.2. Financials
      11.8.3. Key Insights
      11.8.4. Key Strategy
      11.8.5. Product Portfolio
      11.8.6. SWOT Analysis
   11.9. Smiths Medical
      11.9.1. Introduction
      11.9.2. Financials
      11.9.3. Key Insights
      11.9.4. Key Strategy
      11.9.5. Product Portfolio
      11.9.6. SWOT Analysis
   11.10. A&D Medical
      11.10.1. Introduction
      11.10.2. Financials
      11.10.3. Key Insights
      11.10.4. Key Strategy
      11.10.5. Product Portfolio
      11.10.6. SWOT Analysis
*More than 40 Companies are profiled in this Research Report, Complete List available on Request*
"*Financials would be provided on a best efforts basis for private companies"
12. Appendix

   12.1. Abbreviations
   12.2. Sources
   12.3. Research Methodology
   12.4. Bibliography
   12.5. Compilation of Expert Insights
   12.6. Disclaimer
Please select Licence
Single User Licence:
US $4250
Corporate User Licence:
US $6250
Related Reports